newsfilter
← Latest News
PR Newswire·

Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update

Palatin Technologies, Inc. (Nasdaq: PTN), a biopharmaceutical company developing medicines that target the melanocortin receptor ("MCR") system,...